Logo image
Se connecter
Retour
Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study
Article de revue   Avec comité de lecture

Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study

Christophe Pomel, Gwenaël Ferron, Gérard Lorimier, Annie Rey, Catherine Lhomme, Jean Marc Classe, J.M. Bereder, François Quenet, Pierre Meeus, Frederic Marshall, …
European journal of surgical oncology, Vol.36(6), pp.589-593
01/06/2010
DOI: https://doi.org/10.1016/j.ejso.2010.04.005
PMID: 20466507

Résumé

Medicine
The aim of the present study was to prospectively evaluate morbidity of intra-peritoneal hyper-thermic chemotherapy (HIPEC) using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma and, secondly, to study peritoneal recurrence.

Indicateurs

1 Consultations de la notice

Détails

Logo image